van de Vijver MJ - Search Results

1

Validation of 70-gene prognosis signature in node-negative breast cancer.

Bueno-de-Mesquita JM, Linn SC, Keijzer R, Wesseling J, Nuyten DS, van Krimpen C, Meijers C, de Graaf PW, Bos MM, Hart AA, Rutgers EJ, Peterse JL, Halfwerk H, de Groot R, Pronk A, Floore AN, Glas AM, Van't Veer LJ, van de Vijver MJ. Bueno-de-Mesquita JM, et al. Among authors: van t veer lj, de graaf pw, van krimpen c, van de vijver mj, de groot r. Breast Cancer Res Treat. 2009 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub 2008 Sep 26. Breast Cancer Res Treat. 2009. PMID: 18819002

2

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, et al. Schuuring E, et al. Among authors: van de vijver mj, van tinteren h. Cancer Res. 1992 Oct 1;52(19):5229-34. Cancer Res. 1992. PMID: 1394126

3

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Beerman H, Bonsing BA, van de Vijver MJ, Hermans J, Kluin PM, Caspers RJ, van de Velde CJ, Cornelisse CJ. Beerman H, et al. Among authors: van de vijver mj, van de velde cj. Br J Cancer. 1991 Jul;64(1):139-43. doi: 10.1038/bjc.1991.257. Br J Cancer. 1991. PMID: 1854613 Free PMC article. Clinical Trial.

4

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. van de Vijver MJ, et al. N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902. N Engl J Med. 1988. PMID: 2903446

5

Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.

van de Vijver MJ, Mooi WJ, Wisman P, Peterse JL, Nusse R. van de Vijver MJ, et al. Oncogene. 1988 Feb;2(2):175-8. Oncogene. 1988. PMID: 3285295

6

Amplification and over-expression of the neu oncogene in human breast carcinomas.

van de Vijver MJ, Mooi WJ, Peterse JL, Nusse R. van de Vijver MJ, et al. Eur J Surg Oncol. 1988 Apr;14(2):111-4. Eur J Surg Oncol. 1988. PMID: 3360152

7

Ductal carcinoma in situ: a proposal for a new classification.

Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B. Holland R, et al. Among authors: van de vijver mj. Semin Diagn Pathol. 1994 Aug;11(3):167-80. Semin Diagn Pathol. 1994. PMID: 7831528 Review.

8

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cornelis RS, et al. Among authors: van de vijver mj, van vliet m. Cancer Res. 1994 Aug 1;54(15):4200-6. Cancer Res. 1994. PMID: 8033152

9

Molecular genetic changes in human breast cancer.

van de Vijver MJ. van de Vijver MJ. Adv Cancer Res. 1993;61:25-56. doi: 10.1016/s0065-230x(08)60954-9. Adv Cancer Res. 1993. PMID: 8346719 Review. No abstract available.

10

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ. van Slooten HJ, et al. Among authors: van dierendonck jh, van de vijver mj, van de velde cj. Br J Cancer. 1996 Jul;74(1):78-85. doi: 10.1038/bjc.1996.319. Br J Cancer. 1996. PMID: 8679463 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page